Here are four takeaways:
1. The fracture fixation and replacement systems segment was valued at nearly $1.596 million in 2014.
2. The segment is expected to grow at a compound annual growth rate of 8 percent from 2015 to 2023.
3. The increasing prevalence of joint degenerative diseases and increasing healthcare expenditures are fueling the small bone and joint orthopedic devices market’s growth.
4. Key players include Acumed, Arthrex, DJO Global, Flower Orthopedics, DePuy Synthes, Smith & Nephew, Stryker, Tecomet, Wright Medical Group, Zimmer Biomet and Z-Medical GmbH.
More articles on devices:
NuVasive sentiment falls to 1.17 in Q1: 5 notes
Bioventus files for $150M IPO: 5 points
Prosidyan, MO-SCI collaborate on new orthopedic technology — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
